热门资讯> 正文
Blade Air Mobility第二季度业绩喜忧参半
2025-08-05 19:15
- Blade Air Mobility press release (NASDAQ:BLDE): Q2 GAAP EPS of -$0.05 misses by $0.01.
- Revenue of $70.8M (+4.2% Y/Y) beats by $6.72M.
- Medical revenue increased 17.6% year-over-year in Q2 2025
- Net loss improved by $7.6 million versus the prior year to $(3.7) million in Q2 2025; Adjusted EBITDA improved by $2.2 million versus the prior year to $3.2 million in Q2 2025(1)
- Blade Passenger division to be sold to Joby Aviation for up to $125 million; Blade’s Medical division will remain a standalone public company, rebrand as Strata Critical Medical ("Strata")
- Sale is expected to be Adjusted EBITDA and Free Cash Flow neutral on a go forward basis
More on Blade Air Mobility
- Joby Aviation: Why Acquiring Blade Air Mobility Makes Sense
- Blade Air Mobility: Waiting For eVTOLs
- Blade Air Mobility: Fundamentals Continue To Strengthen
- Blade Air Mobility Q2 2025 Earnings Preview
- Biggest stock movers Monday: BLDE, COMM, SPOT, ON, and more
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
